As far as like is it safe to use it, its really a risk versus benefit conversation
Use consistent lighting, monthly photos, and enough time to evaluate the routine objectively
This information provided is general and should not be taken as medical advice
GLP-1 receptor agonists have shown strong efficacy in promoting weight loss and improving glycemic control, making them a preferred choice for patients with obesity, type 2 diabetes, and cardiovascular risk factors
Visual Field Degradation Characteristics: Rather than triggering absolute darkness or total blindness, the condition typically presents as sudden blurring, dimming, or a localized loss of a specific part of the visual field (altitudinal defects) in one eye
Nordisks announcement comes less than two weeks after Eli Lilly, one of the three companies that produce insulin in the U.S., announced that it will cut the list price of some of its older insulins later in 2023 and mirror the new Medicare $35 monthly out-of-pocket cap for consumers with private health insurance